Why Quantify?Solution
available now
Orthopedics
Sports Medicine
Pediatrics
INVESTIGATIONAL
Revolutionizing venous pressure measurement.
Clinical EvidenceCompany
Resources
News
Publications
Whitepapers
Case Reports
Contact us
CPMX1 is now called Compremium Quantis ST

News

Compremium Receives FDA Breakthrough Device Designation for Non-Invasive Central Venous Pressure Measurement System and has also joined FDA’s TAP Program
Featured

Compremium Receives FDA Breakthrough Device Designation for Non-Invasive Central Venous Pressure Measurement System and has also joined FDA’s TAP Program

January 8, 2026
by
Compremium Team
Read
Recent News

Compremium Quantis ST Achieves CE Marking - Now Available Across the EU and Switzerland

December 4, 2025
by
Compremium Team
Read

Compremium Launches First-In-Human Study on Non-Invasive Thyroid Cancer Diagnostic Medical Device

June 18, 2025
by
Compremium Team
Read

Children’s National and Compremium partner on pediatric medtech innovation

February 11, 2025
by
Compremium Team
Read

Compremium captures award at prestigious pediatric medical device competition

October 28, 2024
by
Compremium Team
Read

ISO 13485 Certification: A commitment to quality and innovation

August 14, 2024
by
Compremium Team
Read

CPMX1 is MIL-STD 810H compliant and ready for duty

April 10, 2024
by
Compremium Team
Read

Important advancement in pediatric diagnostics

November 16, 2023
by
Compremium Team
Read

Compremium Corp. receives FDA clearance for the CPMX1 System

April 24, 2023
by
Compremium Team
Read

Long term partnership with NASA for human advancement

December 7, 2022
by
Compremium Team
Read

Very promising reliability of CPMX1 confirmed

November 3, 2022
by
Compremium Team
Read

Experience Compremium Quantis ST in Action.

Compremium Quantis ST is CE-marked and FDA- Cleared.
Book your consultation
Flag of Sweden
Swiss engineered
2026 Compremium AG
Follow us on LinkedIn
Why Quantify?SolutionClinical Evidence
CompanyContact UsPrivacy PolicyData Protection